4/A//SEC Filing
Brettman Ari David 4/A
Accession 0001209191-21-005509
CIK 0001633932other
Filed
Jan 25, 7:00 PM ET
Accepted
Jan 26, 7:01 PM ET
Size
6.0 KB
Accession
0001209191-21-005509
Insider Transaction Report
Form 4/AAmended
ESSA Pharma Inc.EPIX
Brettman Ari David
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-12-11+16,500→ 16,500 totalExercise: $7.00Exp: 2030-12-11→ Common Shares (16,500 underlying)
Footnotes (2)
- [F1]Vesting terms have been amended such that 100% of the options vest after 12 months from the date of grant.
- [F2]The Reporting Person disclaims beneficial ownership of these securities and the inclusion of the securities in this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or any other purpose. The Reporting Person is an employee of The Blackstone Group Inc. or one of its affiliates ("Blackstone"). Pursuant to arrangements between the Reporting Person and Blackstone, the Reporting Person is required to transfer to Blackstone any and all compensation received in connection with his directorship for any company Blackstone invests in or advises.
Documents
Issuer
ESSA Pharma Inc.
CIK 0001633932
Entity typeother
Related Parties
1- filerCIK 0001826320
Filing Metadata
- Form type
- 4/A
- Filed
- Jan 25, 7:00 PM ET
- Accepted
- Jan 26, 7:01 PM ET
- Size
- 6.0 KB